Hosted on MSN3mon
Merck’s MilliporeSigma agrees to acquire Mirus Bio for $600mThe move aims to enhance Merck’s capabilities in viral vector manufacturing for cell and gene therapies. MilliporeSigma specialises in developing and commercialising transfection re-agents known ...
Merck’s new formulation of the mega-blockbuster Keytruda, made in collaboration with Alteogen, could help to keep the drug’s ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback